SUDEP Risk and Individualised Seizure Management: What NICE NG217 Requires

Buccal midazolam administration is the part of epilepsy care most care staff are trained on, and our guide to epilepsy awareness and buccal midazolam training covers that ground. But NICE's current epilepsy guideline, NG217, places equal weight on something less commonly trained: discussing and documenting the risk of Sudden Unexpected Death in Epilepsy (SUDEP) with every patient, from the point of diagnosis onwards. Coroners' Prevention of Future Deaths reports repeatedly cite a failure to discuss or document SUDEP risk as a recurring care failing — which makes this a genuine, separate compliance gap from rescue-medication competency.

SUDEP risk discussion starts at diagnosis, not at crisis point

NG217 is explicit that mortality risk — including SUDEP specifically — should be discussed with patients and their carers from the time of diagnosis onwards, not held back until seizures become frequent or severe. The conversation should cover both the patient's understanding of their individual risk and the practical strategies available to reduce it. For care services, this means SUDEP risk discussion belongs in an initial care-planning conversation, not just in crisis-response training.

The modifiable risk factors staff should know

NG217 identifies specific, modifiable risk factors that care teams can actually influence: medication non-adherence, substance misuse, uncontrolled seizures, and unsafe sleeping arrangements — particularly sleeping alone or without adequate supervision. Of these, medication adherence and seizure control are given particular weight: uncontrolled seizures substantially elevate mortality risk, especially generalised or focal-to-bilateral tonic-clonic seizures. This gives care staff a concrete, actionable checklist rather than a vague awareness message — missed medication doses and unsupervised nighttime sleep are the two factors most directly within a care team's ability to address.

Non-modifiable risk factors still need to be documented

Alongside modifiable factors, NG217 identifies non-modifiable risk indicators that should be captured in a resident or patient's care record: a history of brain injury or central nervous system infection, prior stroke or metastatic cancer, and abnormal neurological findings. These factors don't change what a care team can control day to day, but documenting them properly ensures a resident's overall risk profile is accurately reflected — relevant both for care planning and for any subsequent review following an incident.

Nighttime supervision and seizure-detection devices

For patients identified as higher risk — particularly those who experience seizures during sleep — NG217 recommends considering nighttime supervision arrangements, which may include seizure-detection monitoring devices. This is a specific, assessable care decision rather than a blanket recommendation: it should follow from an individual risk assessment rather than being applied uniformly, and the reasoning behind the decision (or the decision not to introduce supervision) should be documented.

What an individualised seizure management plan should contain

Bringing these elements together, NG217 points toward every patient having a documented, individualised seizure management plan — not a generic epilepsy care protocol applied identically across a service. That plan should record the patient's specific seizure types and triggers, their individual SUDEP risk factors (both modifiable and non-modifiable), the agreed approach to nighttime supervision where relevant, medication adherence support needs, and a clear record that SUDEP risk has actually been discussed with the patient and/or their carers — not just assumed to have happened as part of general diagnosis counselling.

Why this is a distinct compliance gap from rescue medication training

It's possible for a care service to have excellent buccal midazolam administration competency — staff correctly trained, confident and compliant on emergency seizure response — while having no documented evidence that SUDEP risk has ever been discussed with residents or recorded in care plans. These are two separate NICE-recognised standards, and inspection or coronial review is increasingly likely to ask about both. A training audit that only checks rescue-medication competency will miss this gap entirely.

Frequently asked questions

Should SUDEP risk be discussed with every epilepsy patient, or only high-risk cases?
NG217 recommends discussion with all patients and carers from diagnosis onwards — risk level affects how the conversation is framed and what mitigation is prioritised, but the discussion itself isn't reserved only for the highest-risk cases.

How often should a seizure management plan be reviewed?
NG217 doesn't set a single fixed interval, but expects ongoing review, particularly following any change in seizure pattern, frequency, or after a significant incident such as a seizure during sleep.

Does SUDEP risk discussion need to happen in a formal clinical setting?
The discussion should be led by a clinician with appropriate knowledge, but care staff have a role in reinforcing medication adherence support and ensuring nighttime supervision arrangements agreed in the care plan are actually followed day to day.

Epilepsy risk management, beyond emergency medication administration, is a distinct CPD competency area for care and health staff. Explore Learnsignal's CPD courses to keep this training current.

Why a generic epilepsy policy isn't the same as individualised risk management

A home or service can have a technically compliant epilepsy policy on file — seizure recognition training completed, rescue medication protocols signed off — and still fall short of what NG217 actually expects, which is a written risk assessment specific to each individual, covering their own seizure pattern, known triggers, nocturnal seizure risk, and medication adherence history. SUDEP risk isn't evenly distributed across everyone with epilepsy; it concentrates in people with poorly controlled or nocturnal seizures, which is exactly why a blanket policy applied identically to every resident misses the point. CPD content should train staff to read and act on the individual risk assessment, not just to recognise a seizure in progress.